Sequent Scientific Limited
NSE: SEQUENT.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Rajaram Narayanan
- Employees
- 1,195
- Headquarters
- Mumbai, India
- IPO year
- 2016
- Market cap
- ₹50.6B
- Website
- https://www.sequent.in
Loading SEQUENT…
Loading profile data…Frequently asked questions about SEQUENT
What does Sequent Scientific Limited (SEQUENT.NS) do?
Sequent Scientific Limited operates animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also off...
Where does SEQUENT.NS trade?
Sequent Scientific Limited (SEQUENT.NS) trades on the National Stock Exchange of India.
What sector is SEQUENT.NS in?
Sequent Scientific Limited (SEQUENT.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sequent Scientific Limited?
Rajaram Narayanan is the chief executive officer of Sequent Scientific Limited (SEQUENT.NS).
Where is Sequent Scientific Limited headquartered?
Sequent Scientific Limited is headquartered in India.
Does SEQUENT.NS pay a dividend?
Sequent Scientific Limited (SEQUENT.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SEQUENT.NS go public?
Sequent Scientific Limited (SEQUENT.NS) completed its initial public offering in 2016.